hrp0092p1-341 | Fat, Metabolism and Obesity (2) | ESPE2019

ANGPTL2 and ANGPTL3 in Children with Obesity and Metabolic Syndrome

Azar Maryam Razzaghy , Nourbakhsh Mitra , Sadeghabadi Zahra Arab , Nourbakhsh Mona

Introduction: Angiopoietin-like proteins (ANGPTLs) play critical roles in metabolism and are implicated in metabolic consequences of obesity. ANGPTL2 is a key adipocyte-derived inflammatory mediator that links obesity to systemic insulin resistance. ANGPTL3 directly regulate lipid, glucose and energy metabolism independent of angiogenic effects. In this study, we aimed to investigate the levels of ANGPTL2 and 3 in obese children and adolescents and their assoc...

hrp0089p3-p210 | GH & IGFs P3 | ESPE2018

A Pilot Study for Comparing Efficacy and Safety of the CinnaTropin® to the Reference Recombinant Human GH in Children with Isolated GH Deficiency and Multiple Pituitary Hormone Deficiency

Razzaghy-Azar Maryam , Pourmotabbed Abdoreza , Heshmat Ramin , Rezaei Farhang

Background: CinnaTropin® (CinnaGen, Iran) is a recombinant human GH manufactured in Iran. Herein, we compared the efficacy and safety of the CinnaTropin® with the corresponding reference (Nordilet® Norditropin, Novo Nordisk, Denmark) in children with idiopathic GH deficiency (IGHD) and multiple pituitary hormone deficiency (MPHD).Methods: This was a randomized, open-label and cross-over study. Eligible pati...

hrp0086rfc3.3 | Pituitary | ESPE2016

Unraveling the Link between Optic Nerve Hypoplasia and Pituitary Hormone Dysfunction

Alyahaywi Naseem , Dheenshaw Kiera , Aroichane Maryam , Islam Nazrul , Amed Shazhan

Background: Optic nerve hypoplasia (ONH) is a congenital condition with high morbidity. Many children with ONH will develop pituitary hormone dysfunction (PHD), but it is unknown if, or when, this will occur.Objective and hypotheses: Our primary objective was to identify the type, timing and predictors of PHD in children with ONH to help guide the necessity and frequency for pituitary hormone testing.Method: A retrospective chart r...

hrp0086p1-p105 | Bone & Mineral Metabolism P1 | ESPE2016

Effects of Selective GPER-1 Agonist G1 on Bone Growth

Iravani Maryam , Karimian Elham , Chagin Andrei , Savendahl Lars

Background: Abnormal growth is a common problem in children. Some children do not respond to growth hormone therapy and alternative treatments selectively targeting the growth plate are needed. High doses of estrogens induce growth plate closure and stop further growth. However, high-dose estrogen treatment may also have severe side effects, including increased risk of cancer and reduced fertility. The expression of estrogen receptors (ER), including GPER-1, has been demonstra...

hrp0086p2-p323 | Diabetes P2 | ESPE2016

Prevalence of Acute Metabolic Complications in Children with Type I Diabetes Admitted to the Children Hospital in Qazvin, Iran (2005–2014)

Saffari Fateme , Dargahi Maryam , Esmailzadehha Neda , Yazdi Zohre , Homaei Ali

Background: Type 1 diabetes (T1D) is one of the most common chronic diseases in childhood and adolescence. Diabetic ketoacidosis (DKA) and severe hypoglycemia are complications of T1D and are associated with significant morbidity and mortality.Objective and hypotheses: The aim of this study was to determine the prevalence of acute metabolic complications in children with T1D admitted to the children hospital in Qazvin during 2005–2014.<p class="...

hrp0082lbp-d3-1012 | (1) | ESPE2014

Total and Acylated Ghrelin Levels in Children and Adolescents with Growth Retardation

Nourbakhsh Mitra , Latifi Mona , Ilbeygi Davod , Azar Maryam Razzaghy

Background: Ghrelin is a somatotropic and orexigenic protein secreted primarily from stomach.Objective and hypotheses: Since both GH secretion and nutrition, two fundamental contributors in growth promotion, are enhanced by ghrelin, the aim of this study was to investigate the relationship of ghrelin hormone with growth retardation in 3- to 16-year-old children and adolescents and determine whether ghrelin levels are different between normal subjects and...

hrp0084p2-232 | Bone | ESPE2015

Regulation of Bone Growth Via Ligand-Specific Activation of Oestrogen Receptor α

Iravani Maryam , Lagerquist Marie , Ohlsson Claes , Savendahl Lars

Background: Oestrogens are well known for their capacity to promote bone maturation and at high doses to induce growth plate closure and thereby stop further growth. High-dose oestrogen treatment has therefore been used to limit growth in extremely tall girls. However, recent data suggest that this treatment may have severe side effects, including increased risk of cancer and reduced fertility.Objective and hypotheses: We hypothesised that oestrogenic ef...

hrp0097p1-378 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2023

Infant with 45, XO DSD presented with Li Fraumeni syndrome, a case report from Kuwait.

Alfadhli Maryam , Alhenaidi Razan , Elshafie Reem , Alkandari Hessa , Alhomaidah Doha

Background: X-chromosome monosomy is the most common sex abnormality in females, with a higher prevalence of cancer than the general population. Virilizing adrenocortical tumors are rarely seen in patients with Turner’s Syndrome. There have been 2 reported cases of simultaneous TP53 mutations (Li Fraumeni’s syndrome) and Turner’s syndrome. Here we report first case with this rare association from Kuwait.Clinical...

hrp0097p2-226 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2023

Classical CAH girls having early intervention and puberty development.

Abdul Razzaq Ayesha , Waris Rehmana , Naseer Maryam , Waheed Nadia

Introduction: CAH (congenital adrenal hyperplasia) is the most common cause of ambiguous genitalia among girls. 21 Hydroxylase deficiency is the most common type of CAH. If the CAH girls have early intervention and they have started early treatment then they will achieve normal puberty. IF CAH girls have started treatment later in the life then they will present either with precocious puberty or delayed puberty.Methodology:</stro...

hrp0097p2-167 | Thyroid | ESPE2023

Subclinical hypothyroidism in children: epidemiological study of 30 patients

Marzouk Asma , Ammar Mariem , Braik Amina , Laajili Mariem , Kefi Ahlem , thebti rahma , Mzoughi Oumaima , Friha farida , Ben Hssine Sarra , Bouaziz Asma

Introduction:Subclinical hypothyroidism (SH) is defined in children by a moderate rise in TSH (TSH: 4.5-10 mU/l) compared to a normal level of free T4. However, the clinical consequences remain a subject of controversy, hence the need to take a position on the relevance of treating it.Objective: Description of the clinical, biological and evolutionary characteristics of SH in children.Patie...